Press Releases

Flowable Hemostats Market Outlook and Growth Opportunities to 2022-2030

Share This Article

Philanthropic Support and Continuous Supply of Hemostats Crucial amidst COVID-19 Pandemic

Healthcare companies in the flowable hemostats market are increasing the supply of life-sustaining medicines and medical devices such as flowable hemostats amidst dire times of the coronavirus (COVID-19) pandemic. They are expanding job opportunities for individuals to help meet increased product demand. Increasing product supply chain is one of the key focus points for companies in the flowable hemostats market, since COVID-19 is challenging communities and healthcare systems around the world. Manufacturers are maximizing their production activities by making hemostats and other medical devices available round the clock.

Get the sample copy of report@ https://qyresearchmedical.com/sample/111677

In-house medical teams of med-tech companies are actively working with governments, clinicians, and healthcare systems to understand unique challenges created by COVID-19. Leading med-tech companies are extending philanthropic support by providing financial support to frontline healthcare workers and communities. They are extending geographic-specific support in order to improve clinical outcomes.

Fully Stocked Inventory Creates Consistency in Supply Chains for Surgeons

Establishing a robust supply chain has helped med-tech companies in the flowable hemostats market to gain a competitive edge over other market players. As such, the market is highly consolidated with only three players accounting for a combined market share of ~97% during the forecast period. Hence, manufacturers are building their inventory to meet requirements in difficult-to-access bleeding situations. For instance, global leaders in consumer healthcare and medical devices are strengthening their supply for flowable hemostats by entering into strategic partnerships with distributors.

Get a glimpse of the in-depth analysis through our Report Brochure

Companies in the flowable hemostats market are developing devices that work fast and improve visibility. Fast mechanism of advanced flowable hemostats helps to stop difficult-to-access bleeding in less time. Thus, surgeons can count on a fully stocked inventory with a consistent supply of hemostats. Gelatin matrix hemostats are acquiring prominence in the market, as the total combined revenue of porcine and bovine gelatin materials is estimated to reach ~US$ 1 Bn by the end of 2027.

High Demand for Flowable Hemostats in Partial Splenectomy after Penetrating Trauma

Hemostatic agents are in high demand for prehospital hemorrhage control. As such, the revenue of general surgery applications is the highest in the flowable hemostats market. This has fueled the demand for thrombin-gelatin hemostatic matrix in devices, owing to its safety and efficacy profiles. For instance, Baxter International— a leading manufacturer of products for treatment of life-threatening conditions is gaining popularity for its FLOSEAL Hemostatic Matrix, which is better than microporous polysaccharide powder materials. Companies in the flowable hemostats market are increasing efforts to introduce special applicator syringe in devices.

Thrombin-gelatin hemostatic matrix in flowable hemostats are being highly publicized in cardiovascular surgeries, hepatic surgeries, and endoscopic sinus surgeries. There is a growing demand for flowable hemostats that deploy effective hemostasis in partial splenectomy after penetrating trauma. Tranexamic acid-loaded starch microspheres hold promising potentials in hemostatic stability. Likewise, drug-loaded materials are projected to show better hemostatic performance in comparison with commercial hemostat made of microporous polysaccharide hemispheres.

Clinically Proven Hemostats Gain Popularity Due to Stringent Federal Regulations

The flowable hemostats market is expected to expand at a CAGR of ~6% during the assessment period. However, restriction of sales under the federal U.S. law is a challenge that med-tech companies need to overcome. Stringent regulations can inhibit growth of the U.S. flowable hemostats market, which is anticipated to dictate the highest revenue among all regions in the market landscape. Hence, manufacturers are increasing the availability of clinically proven flowable hemostats. For instance, Teleflex Incorporated— the global provider of medical technologies is increasing awareness about its clinically-backed D-Stat® Flowable Hemostat, which helps to reduce incidence of hematoma formation in pulse generator implants.

Med-tech companies are increasing their R&D activities in flowable procoagulants that promote hemostasis by initiating the body’s own clotting mechanism. They are increasing the availability of devices that eliminate the need for needles for mixing the materials. Companies are increasing the availability of hemostats that can be topically applied to control bleeding from vascular access sites and percutaneous catheters and tubes.

View full report@ https://qyresearchmedical.com/report/flowable-hemostats-market-material-porcine-gelatin-and-bovine-gelatin-application-general-surgery-cardiac-surgery-vascular-surgery-neuro-spine-surgery-orthopedic-surgery-and-others-and-end-user-hospital-019-2030/111677

Analysts’ Viewpoint

Companies in the flowable hemostats market are supplying critically needed products via airfreight for fast delivery of products amidst the COVID-19 outbreak. They are increasing production capabilities to develop hemostats that can be used in tissue tract hemostasis post use of vascular closure devices.

Novel hemostats maintain uniformity, consistency, and viscosity in materials from beginning until the end compared to other traditional devices. However, adverse effects of flowable hemostats such as adhesion formation, allergic reaction, and bleeding, among others, are inhibiting market growth. Hence, companies should increase awareness about precautions such as non-utilization of hemostats in the presence of infections to avoid undesirable outcomes in patients.

Flowable Hemostats Market: Overview

The global flowable hemostats market for the historical period 2017–2018 and forecast period 2019–2027, rise in number of trauma and surgical cases is projected to drive the global flowable hemostats market during the forecast period

According to the report, the global flowable hemostats market was valued at ~US$ 700 Mn in 2018 and is anticipated to expand at a CAGR of ~6% from 2019 to 2027

Rise in Number of Trauma and Surgical Cases: Key Driver

Increase in global trauma and accident cases is a major driver of the global flowable hemostats market

According to the World Health Organization (WHO), an estimated 1.25 million people lose their lives in road traffic accidents across the world every year

Globally, hemorrhage or excessive bleeding is responsible for over one third of pre-hospital deaths and over 40% of deaths within the first 24 hours

Moreover, a study conducted by the U.S. Armed Forces suggested that 25% of battlefield fatalities are medically preventable. Nearly 90% of these deaths are due to uncontrolled blood loss.

Such high number of deaths has induced governments to develop and provide better hemorrhage control systems

The patient pool with trauma and different chronic diseases is also rising rapidly across the world. This is likely to increase the number of surgical procedures, consequently propelling the global flowable hemostats market.

Increase in Global Geriatric Population Boosts Market Growth

Increase in the global geriatric population is projected to fuel the demand for hemostats, including flowable hemostats during the forecast period. Rise in geriatric population directly affects the demand for hemostats, primarily due to higher susceptibility to various diseases among the population leading to higher number of surgeries.

The global geriatric population is increasing rapidly. According to the WHO, the global geriatric population is expected to increase from 524 million in 2010 to 1.5 billion by 2050. Aging increases the need of healthcare, as it renders people prone to cardiovascular diseases such as coronary heart disease, respiratory diseases such as TB and pneumonia, dental caries & oral cancer, and orthopedic conditions such as osteoporosis.

Most developed countries have high geriatric population. According to the WHO, the geriatric population is expected to rise at a rapid pace in developed countries such as the U.S., the U.K., and Japan.

Access to various diagnostic and treatment services has improved due to favorable healthcare policies and advancement in healthcare facilities in countries such as the U.S., Japan, the U.K., and other countries in Western Europe. This in turn has increased life expectancy of the population. Increase in geriatric population is anticipated to propel the global flowable hemostats market during the forecast period.

Lack of Awareness in Developing Countries to Hamper Market

Bleeding disorders account for a significant share of the disease burden in developing countries

Von Willebrand disease (VWD) is the most common bleeding disorder across the world. According to Health Grades, Inc., about 3 million people with VWD go undiagnosed globally each year. Prevalence of Von Willebrand disease is high in developing countries such as China and India.

Lack of awareness about bleeding disorders in developing countries is expected to hamper the global flowable hemostats market during the forecast period

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111677/2900

Flowable Hemostats Market: Competition Landscape

This report profiles major players in the global flowable hemostats market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments

The global flowable hemostats market is highly consolidated, with the presence of small number of players

Major players operating in the global flowable hemostats market are Johnson & Johnson, Baxter International, Inc., and Teleflex Incorporated

The report on the global flowable hemostats market discussed individual strategies, followed by company profiles of manufacturers of flowable hemostats. The competition landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global flowable hemostats market.

Flowable Hemostats Market: Key Developments

In January 2018, Baxter International agreed to acquire two hemostat and sealant products from Mallinckrodt plc: RECOTHROM, a thrombin topical (recombinant) and PREVELEAK surgical sealant, which are used in vascular reconstruction

Key Questions Answered in Flowable Hemostats Market Report

  • What is the scope of growth of companies in the global flowable hemostats market?
  • What will be the Y-o-Y growth of the global flowable hemostats market between 2019 and 2027?
  • What is the influence of changing trends in technologies on the global flowable hemostats market?
  • Will North America continue to be the most profitable market for flowable hemostats providers?
  • Which factors will hamper the growth of the global flowable hemostats market during the forecast period?
  • Which are the leading companies in the global flowable hemostats market?

Flowable Hemostats Market – Segmentation

Material

  • Porcine Gelatin
  • Bovine Gelatin

Application

  • General Surgery
  • Cardiac Surgery
  • Vascular Surgery
  • Neuro & Spine Surgery
  • Orthopedic Surgery
  • Others

End User

  • Hospitals
  • Clinics
  • Ambulatory Surgery Centers

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

TABLE OF CONTENT

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Flowable Hemostats Market

4. Market Overview

4.1. Introduction

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.3.4. Key Market Trends

4.4. Global Flowable Hemostats Market Analysis and Forecast, 2017–2027

5. Market Outlook

5.1. Flowable Hemostats Pricing Analysis

5.2. Brand Analysis: Floseal vs. Surgiflo

5.3. Pipeline Analysis: Advanced Hemostasis Products Market

5.4. Regulatory Scenario

5.5. Reimbursement Assessment Overview

6. Global Flowable Hemostats Market Analysis and Forecast, by Material

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Market Value Forecast, by Material, 2017–2027

6.3.1. Porcine Gelatin

6.3.2. Bovine Gelatin

6.4. Market Attractiveness Analysis, by Material

7. Global Flowable Hemostats Market Analysis and Forecast, by Application

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Market Value Forecast, by Application, 2017–2027

7.3.1. General Surgery

7.3.2. Cardiac Surgery

7.3.3. Vascular Surgery

7.3.4. Neuro & Spine Surgery

7.3.5. Orthopedic Surgery

7.3.6. Others

7.4. Market Attractiveness Analysis, by Application

8. Global Flowable Hemostats Market Analysis and Forecast, by End-user

8.1. Introduction & Definition

8.2. Key Findings / Developments

8.3. Market Value Forecast, by End-user, 2017–2027

8.3.1. Hospitals

8.3.2. Clinics

8.3.3. Ambulatory Surgery Centers

8.4. Market Attractiveness Analysis, by End-user

9. Global Flowable Hemostats Market Analysis and Forecast, by Region

…….

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111677/2900

You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333

About Us

QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).

QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.

For Latest Update Follow Us:

https://www.linkedin.com/company/qyresearch-medical/

https://www.facebook.com/QYResearch-Medical-108186514228917/

https://twitter.com/qyresearchmedi

Related Articles

Back to top button